Login| Sign Up| Help| Contact|

Patent Searching and Data


Matches 51 - 100 out of 89,082

Document Document Title
WO/2016/065453A1
The present invention describes an expression cassette for eukaryotic cell transformation, comprising the nucleotide sequence (SEQ ID NO: 2) encoding a xylose isomerase peptide (SEQ ID NO: 1), optionally also comprising other genes of th...  
WO/2016/070151A1
The present disclosure provides methods, systems, compositions, and kits to address the need for microbiome-related treatment of health conditions and disease. Specifically, the disclosure provides methods for treatment of metabolic cond...  
WO/2016/065470A1
A microfluidic device, method and kit for assaying and/or culturing cells are provided. The microfluidic device comprises a well block comprising a plurality of microwells; at least one cell culture layer selected from a first cell cultu...  
WO/2016/068427A1
The present invention relates to an interleukin-2 expression construct for yeast and yeast containing same, the expression construct comprising: a methanol oxidase promoter; human serum albumin (HSA) or a fragment gene thereof; and an in...  
WO/2016/069155A2
The present disclosure provides methods for biosynthesis of acetaminophen. The present disclosure provides host cells genetically modified to provide for production of acetaminophen.  
WO/2016/066896A1
The invention relates to novel variants of fungal endoglucanases, their production and means for their production. Especially the invention relates to variants of Acremonium thermophilum Cel45A. The invention further relates to enzyme pr...  
WO/2016/068093A1
Provided is Frateribacillus flavoalbus, which is a novel species of Frateribacillus and includes the following properties: 1) the microorganism is gram-negative and forms spores; 2) the microorganism is oxidase-negative, catalase-positiv...  
WO/2016/068428A1
The present invention relates to a method for producing an interleukin-2 protein using methylotrophic yeast. The method for producing interleukin-2 of the present invention shows a high growth and protein synthesis rate by establishing a...  
WO/2016/068218A1
The present invention addresses the problem of providing a novel enzyme that exhibits a cholesterol dehydrogenase activity. Provided is a mutated enzyme that comprises an amino acid sequence derived from the amino acid sequence of a micr...  
WO/2016/063637A1
Provided is a method for screening a compound, said compound being capable of specifically inhibiting the formation of caveolae in cancer cells and comprehensively inhibiting various RTK activities only by the single compound. A screenin...  
WO/2016/062771A1
The invention relates to products and compositions that may be beneficial in animal husbandry. Said products and compositions comprise microorganisms, such as bacteria, and probiotic bacteria in particular. Thus, provided herein are micr...  
WO/2016/061827A1
The present invention relates to a biological degumming method for ramie. The method comprises the following steps: using bacillus (Bacillus sp. HG-28) as a strain; obtaining a degumming bacteria solution F used for biological degumming ...  
WO/2016/065341A1
Delivering a payload across a plasma membrane of a cell includes providing a population of cells and contacting the population of cells with a volume of an aqueous solution. The aqueous solution includes the payload and alcohol content g...  
WO/2016/064146A1
The present invention relates to a composition for preparing tagatose, wherein the composition is used for preparing tagatose from fructose and contains a protein including any one amino acid sequence of SEQ ID NOS: 1 to 7 or a strain ex...  
WO/2016/064000A1
The present invention relates to Lactobacillus plantarum Probio 090 having antiviral and antipathogenic bacterial activities and, more specifically, provides: Lactobacillus plantarum Probio 090 for inhibiting the activity of viruses and ...  
WO/2016/065085A1
Apparatuses and associated methods are described for the efficient evaluation of C1-containing substrates, and especially for such evaluation conducted locally, or on-site, at a prospective facility for implementation of a biological con...  
WO/2016/063516A1
Provided is an organism and substance manufacturing method that enables appropriate control of organism proliferation and substance production. The organism has equipped in DNA: a proliferation participating region that relates to organi...  
WO/2016/064245A1
A novel peptide compound, a production method therefor, and a use thereof are provided. The compound has an anticancer activity, and thus the compound can be used for preventing or treating cancer.  
WO/2016/061696A1
By this invention, for the first time, a method for high-efficiency generation of gene knockouts in the anaerobic bacterium Clostridium pasteurianum is provided. Clostridium pasteurianum is a bacterium of substantial industrial importanc...  
WO/2016/062836A1
The invention relates to a capsule comprising: an inner phase comprising at least one plant cell, and an outer gel phase that encapsulates the entire inner phase on the periphery thereof, said outer phase comprising at least one surfacta...  
WO/2016/064643A1
The current invention provides a recombinant bacterium, the recombinant bacterium being genetically modified to decrease or eliminate the display of lipoteichoic acid (LTA), surface layer protein B (SlpB) and surface layer protein X (Slp...  
WO/2016/062171A1
Provided are genes, coding proteins and uses thereof, gene elements, genes and uses, gene elements, methods for synthesizing odd numbered medium chain aliphatic aldehydes, for synthesizing odd numbered medium chain aliphatic alcohol and ...  
WO/2016/058096A1
A process for manufacturing a biodegradable bioactive film product, the process comprising: a) isolating polyhydroxyalkanoate from a bacterial culture; b) optionally bleaching the polyhydroxyalkanoate; c) dispersing the polyhydroxyalkano...  
WO/2016/060171A1
 The purpose of the present invention is to provide a yeast having an improved capability to produce ethanol from xylose. The present invention provides a transformed yeast in which a xylose utilization gene and enzyme genes of a pento...  
WO/2016/060437A1
The present invention relates to a microorganism of the genus Corynebacterium for producing L-arginine and an L-arginine production method using same.  
WO/2016/059058A1
The invention relates to a method for producing membrane polysaccharides from an organism selected from micro-organisms, unicellular organisms and filamentous fungi, said method comprising at least one step of extracting said membrane po...  
WO/2016/061275A1
This disclosure describes modified photosynthetic microorganisms, including Cyanobacteria that produce carotenoids, including zeaxanthin, astaxanthin, and/or canthaxanthin. The modifications include one or more genetic modifications such...  
WO/2016/060892A1
In one embodiment, an algae cultivation system includes a passive membrane photobioreactor having an interior space in which algae can be cultivated and a porous membrane that separates growth media from the interior space, wherein water...  
WO/2016/061339A1
Disclosed is a method for modifying yeast to enhance yield of the fermentation primary product, and decrease glycerol in fermentation co-products. The method comprises contacting yeast with a benzoic organic salt followed by yeast fermen...  
WO/2016/059541A1
Provided herein are methods of culturing a microorganism. The method includes providing a container comprising one or more microorganisms and medium, wherein the microorganisms and medium form a start volume. The microorganisms and mediu...  
WO/2016/059540A1
Provided herein are methods of culturing a microorganism. The methods include providing a container comprising one or more microorganisms in a medium, which has a first carbon to nitrogen ratio; culturing the microorganisms until the cul...  
WO/2016/061115A1
The present invention relates to the preparation and use in primates of whole organismvaccines in which the MEP pathway is disrupted such that synthesis of HMBPP by the bacterial cells is substantially blocked. The data provided demonstr...  
WO/2016/059262A1
The invention relates to a method for the enrichment of microalgae biomass, in particular of the genus Nannochloropsis, in different polyunsaturated fatty acids, primarily docosahexaenoic acid (22:6n-3, DHA), using oils rich in these fat...  
WO/2016/058097A1
A process for manufacturing a biodegradable polymer filament product, the process comprising: a) isolating polyhydroxyalkanoate from a bacterial culture; b) optionally bleaching the polyhydroxyalkanoate; c) dispersing the polyhydroxyalka...  
WO/2016/056773A2
The present invention relates to a Corynebacterium glutamicum mutant strain having resistance to high-concentration L-glutamine and a method for producing L-glutamine using the same.  
WO/2016/056650A1
The purpose of the present invention is to identify a novel gene that effectively increases plant biomass, and to provide said gene and a use therefor. The present invention provides: a nucleic acid that encodes a protein characterized b...  
WO/2016/056944A1
The invention relates to the microbiological industry, microbiology and biotechnology, and specifically to the production of physiologically active compounds, and concerns the production of a protein, bacteriorhodopsin, by means of mi...  
WO/2016/054792A1
The present invention provides a mutant polypeptide comprising the amino acid sequence of Escherichia coli tetracycline efflux pump A (TetA), and a polynucleotide encoding the polypeptide. The present invention provides a first expressio...  
WO/2016/056662A1
 Provided is a viscosity reducer for a mannan-containing material, whereby the utility of mannan can be enhanced. A viscosity reducer for a mannan-containing material, including a polypeptide provided with an additional sequence in whi...  
WO/2016/056630A1
 A cell culture bag 10 is provided with: a plurality of gas-permeable tubular portions 11 separated from each other by partition walls, the tubular portions 11 having a tubular axis direction directed along a first direction and being ...  
WO/2016/056566A1
Provided are: a transformant that is capable of producing lactic acid at a high productivity without requiring neutralization with an alkaline agent, and has excellent lactic acid production ability and excellent proliferation potency; a...  
WO/2016/056592A1
The present invention addresses the problem of providing a method for efficiently culturing 1,4-dioxane-decomposing bacteria. The solution is to provide a method for culturing 1,4-dioxane-decomposing bacteria characterized by the use of ...  
WO/2016/057654A1
Engineered stable multi-organism (or multi-cell type) communities encapsulated in a media that slows or prohibits certain metabolic functions such as cell division, but maintains other metabolic functions.  
WO/2016/055879A1
The present invention refers to a process designed to increase the production of plant growth-promoting microorganisms of the Bacillus genus, using a culture medium poor in nutrients and with specific environmental conditions, allowing t...  
WO/2016/050861A1
The present invention relates to methods for cultivating a nitrile hydratase producing microorganism, compositions for cultivating a nitrile hydratase producing microorganism, and use of compositions comprising a saccharide and an organi...  
WO/2016/051983A1
The present invention addresses the problem of providing a cell culture medium, particularly a serum-free cell culture medium, in which the cell proliferation efficiency can be improved without requiring the use of feeder cells. Accordin...  
WO/2016/050654A1
Suggested is a culture of Amycolatopsis sp. ATCC 39116 - mutant F33 or mutant F86 which converts ferulic acid into vanillin.  
WO/2016/049918A1
Biomarkers and methods for predicting the risk of a disease related to microbes are provided, in particular coronary artery disease (CAD) or related heart diseases.  
WO/2016/050111A1
Biomarkers for rheumatoid arthritis (RA) are described. RA-associated metagenomic linkage groups (MLGs) have been identified and validated in gut and oral microbiotas. These MLGs are used in systems, methods and products for identifying ...  
WO/2016/053309A1
The invention relates to creped prebiotic tissue products. The tissue products comprise prebiotics in sufficiently high amounts to have a prebiotic effect in use, without negatively affecting tissue product properties, such as tensile st...  

Matches 51 - 100 out of 89,082